StockData
Liquidia Corp logo

Liquidia Corp (LQDA) stock

LQDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3079% above fair value
$54.43−2.20 (-3.88%)

Close on Nov 20, 2026Market cap $4.87BP/E 39.2Yield –

Liquidia free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Liquidia's free cash flow for the twelve months ending Jun 30, 2026 was $150.69M. For fiscal 2025 it was -$40.02M. The highest annual figure on record is -$29.18M in fiscal 2022.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$40.02M–
FY2024Dec 31, 2024-$98.37M–
FY2023Dec 31, 2023-$42.85M–
FY2022Dec 31, 2022-$29.18M–
FY2021Dec 31, 2021-$34.14M–
FY2020Dec 31, 2020-$54.90M–
FY2019Dec 31, 2019-$50.13M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$69.01M–
Q1 FY2026Mar 31, 2026$50.16M–
Q4 FY2025Dec 31, 2025$42.21M–
Q3 FY2025Sep 30, 2025-$10.68M–
Q2 FY2025Jun 30, 2025-$40.54M–
Q1 FY2025Mar 31, 2025-$31.01M–
Q4 FY2024Dec 31, 2024-$22.10M–
Q3 FY2024Sep 30, 2024-$26.83M–
Q2 FY2024Jun 30, 2024-$23.95M–
Q1 FY2024Mar 31, 2024-$25.49M–
Q4 FY2023Dec 31, 2023-$16.19M–
Q3 FY2023Sep 30, 2023-$12.04M–
Q2 FY2023Jun 30, 2023-$5.81M–
Q1 FY2023Mar 31, 2023-$8.82M–
Q4 FY2022Dec 31, 2022-$5.09M–
Q3 FY2022Sep 30, 2022-$5.87M–
Q2 FY2022Jun 30, 2022-$8.44M–
Q1 FY2022Mar 31, 2022-$9.78M–
Q4 FY2021Dec 31, 2021-$7.58M–
Q3 FY2021Sep 30, 2021-$5.83M–
Q2 FY2021Jun 30, 2021-$8.29M–
Q1 FY2021Mar 31, 2021-$12.44M–
Q4 FY2020Dec 31, 2020-$14.13M–
Q3 FY2020Sep 30, 2020-$12.63M–
Q2 FY2020Jun 30, 2020-$13.52M–
Q1 FY2020Mar 31, 2020-$14.62M–

More Liquidia figures

See a number that looks wrong?